Curaleaf Holdings Inc. (CURLF)
OTCQX OTCQX Primary 
Best Marijuana Stocks to Watch Right Now
The U.S. cannabis industry continues evolving in 2025. Investors are watching major multi-state operators closely as legalization debates continue. Many traders remain cautious after repeated sector pullbacks. However, long-term growth expectations still look strong. Because of this, investors are searching for companies with real revenue, strong national footprints, and disciplined expansion plans.
Why I'm Buying Curaleaf Before The 2026 Hemp Ban Kicks In
Curaleaf Holdings, Inc. stands to benefit from the impending federal ban on hemp-derived THC, potentially reversing price compression and boosting margins. CURLF trades at a significant discount to peers, with EV/sales at 2.18x and price/sales at 1.37x, despite strong cash flow and margin performance. International growth remains robust, compounding at 56% YoY, offering long-term upside as new markets mature.
2 Marijuana Stocks For Better Investing In 2026
Marijuana stock investors are awaiting the next jump in the market. More people are readjusting their strategies to prepare for this upcoming trading year. There is another push for a chance to federally legalize cannabis. When the campaign begins, shareholders will take better market action. History has shown that when federal reform news shows progression, it reflects well in the public sector for most pot stocks.
Curaleaf Holdings Shares Fell After Earnings, But It Leads The Cannabis Pack
Curaleaf Holdings, Inc. remains the leading cannabis company by market cap, despite ongoing EPS losses and post-earnings share volatility. CURLF's latest quarterly results beat revenue and EPS forecasts, but shares declined after the report, reflecting continued sector uncertainty. The stock's upside is tied to U.S. federal marijuana reform, particularly rescheduling or legalization, which could unlock explosive growth for CURLF.
Curaleaf Holdings, Inc. (CURLF) Reports Q3 Loss, Beats Revenue Estimates
Curaleaf Holdings, Inc. (CURLF) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.07 per share a year ago.
3 Marijuana Stocks To Add To Your Portfolio Before The Next Bounce
Marijuana stock investors are keeping an open mind and close attention to the industry. Right now, another push for federal reform is being made in addition to companies getting ready to report Q3 2025 financial reports. Also, a lot is happening on the business side of the cannabis industry. What this looks like is companies establishing and ramping up production to meet new market demand.
Top U.S. Marijuana Stocks to Watch in October 2025: Trulieve, Curaleaf, and Green Thumb Dominate the Industry
The U.S. cannabis industry continues to show remarkable strength as legalization momentum grows nationwide. Analysts project the market will exceed $45 billion by 2025, reflecting strong consumer demand and expanding state-level access. In addition, the cannabis sector supports over 400,000 full-time jobs and contributes billions in tax revenue each year. Recent headlines suggest the federal government may soon revisit reclassification, fueling optimism among investors and operators alike. As states add dispensaries and loosen regulations, top marijuana companies with strong retail networks and brand recognition are well-positioned for growth. Therefore, investors are closely watching U.S. marijuana stocks this week as industry sentiment improves and market catalysts align.
Should You Buy or Sell CURLF Stock Amid Renewed Legalization Hopes?
Curaleaf's shares have soared over 200% on renewed legalization optimism, but domestic weakness and profit hurdles cloud the outlook.
The Best Marijuana Stocks Before Federal Reform Is Passed
Marijuana stock investors are waiting patiently with high hopes. Over the last two weeks, the cannabis sector has seen some strong upward trading. This came after Donald Trump expressed his stance on federal reform, stating that he believes there is a place for it. Once that message hit the public, a bulk of the top marijuana stocks began to run. The profits that were taken were a nice pay for some and a restored confidence in what can happen.
Curaleaf Holdings, Inc. (CURLF) Q2 2025 Earnings Call Transcript
Curaleaf Holdings, Inc. (OTCPK:CURLF) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants Boris Alexis Jordan - CEO & Chairman Camilo Russi Lyon - Chief Investment Officer Edward Kremer - Chief Financial Officer Conference Call Participants Aaron Thomas Grey - Alliance Global Partners, Research Division Frederico Yokota Choucair Gomes - ATB Capital Markets Inc., Research Division Jesse Pytlak - Cormark Securities Inc., Research Division Mohammed Hossain - Unidentified Company Russell Stanley - Beacon Securities Limited, Research Division William Joseph Kirk - ROTH Capital Partners, LLC, Research Division Operator Good afternoon, and welcome to the Curaleaf Holdings, Inc. Second Quarter 2025 Conference Call. [Operator Instructions] Please note that this event is being recorded.
Curaleaf Holdings, Inc. (CURLF) Reports Q2 Loss, Misses Revenue Estimates
Curaleaf Holdings, Inc. (CURLF) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.06 per share a year ago.
3 Marijuana Stocks For Speculative Buyers To Consider
Are you buying marijuana stocks or holding onto old positions, and what is keeping investors going? It's the speculation that may take place even though the entire cannabis industry has fallen by the billions. Still, some see the opportunity in the transition and evolution of the legal cannabis industry. The uncertainty of federal reform and other global and US industry issues gives shareholders more concern. Yet the market is not dead, and consumer demand is rising, so the light at the end of the tunnel will be the companies that are most profitable and compliant.
